Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
500
NCT05014555
Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
Phase: N/A
Role: Lead Sponsor
Start: Jul 5, 2023
Completion: Jan 31, 2024
NCT05908006
Validation Study of the Velacur System in Comparison to MRE & MRI-PDFF in Patients With (Suspected) Liver Disease
Start: Jul 15, 2023